VivaLNK's Chemotherapy Patient Monitoring

VivaLnk, Inc.

VivaLNK's Chemotherapy Patient Monitoring

Reducing hospitalizations and complications with remote patient monitoring

Remote Patient Monitoring

Do you know anyone using VivaLNK's Chemotherapy Patient Monitoring?

AlacrityCare is an early-stage digital health company offering new ways to manage the side effects of cancer treatments. Through continuous monitoring solutions, AlacrityCare’s data-driven software provides real-time guidance that enables safer and more personalized interventions than ever before.

Problem:

Each year, 4.8M cancer-related hospitalizations are costing the healthcare system over $58B. Twenty to fifty percent of hospitalizations are avoidable with improved monitoring and patient management.

Solution:

  • Remote monitoring and analytics solution to connect providers with patients throughout the treatment journey.

  • Predictive algorithms designed to offer decision support and notifications for personalized, early intervention to avoid costly events.

Benefits:

  • Reduce hospital readmissions through remote health monitoring.

  • Identification of high risk signals up to 20 hours before hospitalization.

Sensor Data Analyzed:

  • ECG Rhythm
  • Body Temperature
  • Heart Rate
  • Respiratory Rate
VivaLNK's Chemotherapy Patient Monitoring